Guardion Health Sciences — Investor Presentation (March 2021)
20 slides from Guardion Health Sciences's investor presentation, Mar 16, 2021
Slide 1: Corporate Presentation
HEALTH SCIENCES Corporate Presentation Nasdaq: GHSI March 2021
Slide 2: Forward Looking Statement
FORWARD LOOKING STATEMENT This presentation of Guardion Health Sciences, Inc. (the “company,” “Guardion,” “we,” “us,” or “our”) includes "forward-looking statements" intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These stat
Slide 3: About Guardion Health Sciences
About Guardion Health Sciences Guardion Health Sciences (NASDAQ: GHS]), is a clinical nutrition and diagnostics company. GHSI offers a portfolio of science-based, clinically supported nutritional supplements, medical foods, and diagnostic products that support healthcare professionals, their patient
Slide 4: Investment Highlights
Investment Highlights Ye Differentiated and established product portfolio of proven nutrition, medical foods, and diagnostic devices with a historical focus in ocular health and immune health *“* Commercial-stage products with potential to scale revenue in both U.S. and foreign markets “* Strong pro
Slide 5: Nutrition — Large, Growing, Global Market
Nutrition — Large, Growing, Global Market All segments - supplements, clinical nutrition & medical foods - showing strong growth Global Supplement and Medical Food Market Global Players cosh] @ Size and Growth (2020- 2030) 350 Eye Health _~ 300 - 1.3 Medical Food fl 6.1 Eye Health ems 2 250 Suppleme
Slide 6: Clinical Nutrition Industry
Clinical Nutrition Industry VITAMINS & SUPPLEMENTS > Evidence Based CLINICALLY Abbott UA resents SUPPORTED > Clinically Supported Nutrition KABI NUTRITION —_— > Medically Endorsed/Supervised «Nestlé o HealthScience PHARMACEUTICALS Nasdaq: GHSI
Slide 7: Growth Drivers of Clinically Supported Nutrition
Growth Drivers of Clinically Supported Nutrition (s Increasing awareness of the importance of nutrition >) ** Growing body of research demonstrating benefits of nutrition “+ Increasing geriatric population with unique nutritional needs “+ Increasing rate of chronic illness that may benefit from nutr
Slide 8: Ocular Health
Ocular Health Nasdaq: GHSI GUARDION
Slide 9: Opportunity in the Large Ocular Health Sector
Opportunity in the Large Ocular Health Sector The ocular nutrition market is expected to grow at a 6% CAGR, driven by Age-related Macular Degeneration (“AMD”) and glaucoma, which are primary treatment focus areas of Guardion Market Value (US $ Bn) Re oO RB a oN 4.0 0.8 02 i q2 14 2020 = AMD = Dry Ey
Slide 10: Company's Ocular Health Products
Company's Ocular Health Products Lumega-Z (“LMZ”): Designed to replenish and restore the macular protective pigment. A depleted macular pigment is a risk factor for macular degeneration HEALTH SCIENCES GlaucoCetin Designed to support and protect the mitochondrial function of optic nerve cells and im
Slide 11: Ocular Health Growth Initiatives
Ocular Health Growth Initiatives *Grow the current customer base by leveraging technology to increase awareness + Increase consumer awareness with increased marketing ** Improve the customer experience “Strengthen relationship with eye care providers “* Highly-targeted virtual education programs to
Slide 12: Immune Health
Immune Health Nasdaq: GHSI GUARDION
Slide 13: Opportunity in A Growing Sector
Opportunity in A Growing Sector Immune Health $37.7 Billion Key Market Drivers 40 oo + Increasing health consciousness and awareness of & 35 zg ee nutrition among patients and providers Za #” 30 & 2) oF + Growing at-risk geriatric population 2 25 8 20 + Rising rate of chronic immune illnesses O > o
Slide 14: Company's Immune Health Products
Company's Immune Health Products HEALTH SCIENCES (i } +S _— 4 F a F r = = NutriGuard ImmuneSF Astramern Astra H Astramern Astra V Nutritional supplement Malaysia Customized, Malaysia Customized, product developed “private label” product “private label” product under the Nutriguard that contains spec
Slide 15: Immune Health Growth Initiatives
Immune Health Growth Initiatives **Grow the current customer base by leveraging technology to increase svareness \ “Expand distribution via third party eCommerce platforms “Improved technology interface (GHSI website, GHSI eCommerce platform, etc.) “Evaluate international markets to increase sales “
Slide 16: Growth Strategy
Growth Strategy GUARDION
Slide 17: Current Growth Initiatives
Current Growth Initiatives i. Evaluate merger and acquisition opportunities “+ Build product portfolio “+ Build and strengthen distribution channels * Accelerate and diversify top line revenue and EBITDA *» Accelerate Digital Solutions/Digital Platform *» Accelerate evidence-based initiatives “ Imme
Slide 18: Current Growth Initiatives (continued)
Current Growth Initiatives (continued) 4. Strengthen clinical evidence to create differentiation *» New studies to demonstrate the value of Lumega-Z for a wider range of macular degeneration patients “» New studies show benefit of Lumega-Z for other conditions: glaucoma and diabetic retinopathy *» F
Slide 19: Leadership Team
Leadership Team Bret Scholtes David W. Evans, PhD Andrew Schmidt Susan Klein, ND Director Director Vice President and Chief Director of Chief Executive Officer Chief Science Officer Financial Officer Medical Education President Robert N. Weingarten Mark Goldstone Kelly J. Anderson Director Donald A.
Slide 20: For More Information
HEALTH SCIENCES FOR MORE INFORMATION: Investor Relations CORE IR Scott Arnold (516) 222-2560 scotta@coreir.com guardionhealth.com Nasdaq: GHSI GUARDION
Guardion Health Sciences — Investor Presentation (March 2021) on 6ix